Wedbush Adjusts Price Target on Vigil Neuroscience to $23 From $22 on Heels of Sanofi Investment, Maintains Outperform Rating
Wedbush Adjusts Price Target on Vigil Neuroscience to $23 From $22 on Heels of Sanofi Investment, Maintains Outperform Rating
Wedbush将Vigil Neuroscience的目标股价从22美元上调至23美元,得益于赛诺菲安万特的投资,仍然保持跑赢大盘评级。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册